1. Outcomes in African Americans and Hispanics with lupus nephritis
G. Contreras, O. Lenz, V. Pardo, E. Borja, C. Cely, K. Iqbal, N. Nahar, C. de La Cuesta, A. Hurtado, A. Fornoni, L. Beltran-Garcia, A. Asif, L. Young, J. Diego, M. Zachariah, B. Smith-Norwood 
Kidney International 
Volume 69, Issue 10, Pages (May 2006)
DOI: /sj.ki
Copyright © 2006 International Society of Nephrology Terms and Conditions

2. Figure 1
Free of doubling creatinine, ESRD, or death as a function of race/ethnicity. The cumulative probability to remain free of a composite end point of doubling serum creatinine, ESRD, or death for Caucasians, Hispanics, and African-Americans during 72-months of follow-up is shown. *P=0.04 for African Americans vs Caucasians and #P=0.05 African Americans vs Hispanics.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

3. Figure 2
Free of doubling creatinine or ESRD as a function of race/ethnicity. The cumulative probability to remain free of a composite end point of doubling serum creatinine or ESRD for Caucasians, Hispanics, and African-Americans during 72-months of follow-up. P=0.06 for African Americans vs Caucasians or Hispanics.
Kidney International  , DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions